• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Oncology

Preoperative MRI staging shows no risk reduction of breast cancer recurrence

byAndrew Bishara
January 10, 2014
in Oncology, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD

1. Preoperative magnetic resonance imaging (MRI) in breast cancer did not significantly affect local or distal recurrent breast cancer in a meta-analysis of 4 studies.

Evidence rating level: 2 (Good)

Study Rundown: There is currently a great deal of uncertainty regarding the use of MRI in staging newly diagnosed breast cancer in women, particularly in the preoperative setting. A few studies have investigated the long-term effect of MRI on in-breast recurrence, with most studies finding no association. However, given the limited statistical power of single studies, the goal of this meta-analysis was to more definitively examine the association between preoperative MRI and local and distal recurrence in women treated for breast cancer.

In total, four eligible studies contributed data to this analysis. The authors found that eight-year local recurrence free survival did not differ between the MRI and non-MRI groups, nor was any difference found in sensitivity analysis. As a secondary outcome, the authors’ multivariable model showed no significant effect of MRI on distal recurrence free survival. Based on these findings, the authors concluded that preoperative staging MRI in breast cancer does not reduce the risk of recurrence. They also suggest that additional disease detected only by MRI is inconsequential. These conclusions are supported by many strengths of this study, including its large scale with a relatively large number of events, use of IPD and multivariate analysis for confounding, and use of sensitivity analysis. However, it should be noted that this meta-analysis only included four studies, with relatively modest follow-up, and that three of the included studies were non-randomized. Furthermore, it is possible that associations between staging MRI and recurrence may be found with longer follow-up.

Click to read the article in JCO

Relevant reading: Review of preoperative magnetic resonance imaging (MRI) in breast cancer: Should MRI be performed in all women with newly diagnosed, early stage breast cancer?

RELATED REPORTS

#VisualAbstract: Tamoxifen increases the risk of endometrial cancer in premenopausal women with breast cancer

Religious-based interventions improve illness perception in breast cancer patients

Wellness Check: Spirituality

In-Depth [individual person data meta-analysis]: This was an individual person data (IPD) meta-analysis using data from published studies that compared cohorts of female breast cancer patients who received preoperative assessment with conventional imaging versus conventional imaging in addition to preoperative MRI. To be eligible, studies had to have reported comparative data on local recurrence as a primary outcome. All modes of surgical treatment for breast cancer were included, and minimum follow-up calculated from date of surgery was 90 days. Ultimately, four eligible studies contributed data on 3180 affected breasts in 3169 patients. One study was a randomized controlled trial, and three were non-randomized studies. There was a median follow-up of 2.9 years. Survival analysis was used to investigate time to local recurrence and to estimate the hazard ratio for MRI.

Upon analysis, the authors found that eight-year modeled local recurrence free survival did not differ between the MRI (97%) and non-MRI (95%) groups (p = 0.87). There was no significant effect of MRI on LR-free survival, with a hazard ratio of 0.88 (95% CI, 0.52 to 1.41; p = 0.65), though age, margin status, and tumor grade were all associated with LR-free survival (p < 0.05). The HR for MRI was 0.96 (95% CI, 0.52 to 1.77, p = 0.90). Furthermore, eight year distal recurrence free survival did not differ between the MRI (0.89%) and non-MRI (93%) groups, with the HR for MRI 1.18 (95% CI, 0.76 to 2.27; p = 0.48).

By Monica Parks and Andrew Bishara

More from this author: Rituximab linked with reduced chronic immune disease following stem cell transplantation, High-dose prophylaxis for hemophilia increases costs with minimal benefit, Ambrisentan found ineffective against idiopathic pulmonary fibrosis

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: Breast Cancerbreast surgerycancer stagingmeta-analysispreoperative mrirecurrencewomen
Previous Post

Hands-on ophthalmic training for medical students may improve knowledge base

Next Post

Isolated thrombocytopenia uncommon in children treated for ALL [Pediatrics Classics Series]

RelatedReports

#VisualAbstract: Tamoxifen increases the risk of endometrial cancer in premenopausal women with breast cancer
StudyGraphics

#VisualAbstract: Tamoxifen increases the risk of endometrial cancer in premenopausal women with breast cancer

January 24, 2023
Palliative care consultation linked to lower deaths by failed code resuscitation
Oncology

Religious-based interventions improve illness perception in breast cancer patients

January 9, 2023
Early palliative care may improve survival in advanced cancer
Wellness

Wellness Check: Spirituality

January 5, 2023
Oncology

Patients with HER2-positive advanced breast cancer and pathological complete response to neoadjuvant systemic therapy may not require surgical intervention

October 31, 2022
Next Post

Isolated thrombocytopenia uncommon in children treated for ALL [Pediatrics Classics Series]

Preperitoneal mesh placement a valid option for ventral hernia repair

Antepartum and intrapartum events both linked to neonatal HIE

Levetiracetam exposure in utero not associated with neurodevelopmental delays

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Aspirin thromboprophylaxis noninferior to low-molecular-weight heparin in patients with fractures
  • Catheter ablation reduces rates of persistent atrial fibrillation and atrial tachyarrhythmia
  • Deep intronic FGF14 repeat expansion associated with late-onset cerebella ataxia
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options